MedTech Acquisition Corp
Completed 2023-08-10- CIK 1826667
- MTAC
- Now TLSI
- IPO 2020-12-21
- $12.1M trust
- 489 filings
Filings, by quarter
489 filings over 24 quarters; dark bars carry a milestone
- 20 Q4: 21 filings
- 21 Q1: 10 filings
- 21 Q2: 8 filings
- 21 Q3: 5 filings
- 21 Q4: 5 filings
- 22 Q1: 14 filings
- 22 Q2: 2 filings
- 22 Q3: 4 filings
- 22 Q4: 23 filings
- 23 Q1: 16 filings
- 23 Q2: 30 filings
- 23 Q3: 65 filings
- 23 Q4: 17 filings
- 24 Q1: 14 filings
- 24 Q2: 38 filings
- 24 Q3: 27 filings
- 24 Q4: 27 filings
- 25 Q1: 34 filings
- 25 Q2: 43 filings
- 25 Q3: 15 filings
- 25 Q4: 14 filings
- 26 Q1: 24 filings
- 26 Q2: 24 filings
- 26 Q3: 9 filings
- S-1 filed 20 Q4
- IPO 20 Q4
- Completed 23 Q3
Successfully merged with TriSalus Life Sciences, Inc. • Now trading as TLSI
SPAC Overview
$250M
IPO Size
$12.1M
Trust (as of 2023-06-30)
Completed
Current Status
2020
IPO Year
Timeline Progress
About
MedTech Acquisition Corporation is a blank-check company seeking to complete a business combination. It intends to focus on businesses primarily operating in the healthcare sector in the United States.
Investment Focus
Healthcare
Geographic Focus
United States
Key Information
IPO Date
2020-12-21
Total Redemptions
$17.9M
PIPE
$40.2M
Jurisdiction of Incorporation
Delaware
SIC
6770
Completion Date
2023-08-10
Merger Target
TriSalus Life Sciences, Inc.
SPAC Ticker
MTAC
Merged Ticker
TLSI
Stock Performance
TLSI
Trading Symbol
First Trade
2021-02-08
$11.00
At Merger
2023-08-14
$11.51
+5%
6 Months Post-Merger
2024-02-12
$9.50
-17%
1 Year Post-Merger
2024-08-13
$5.75
-50%
2 Years Post-Merger
2025-08-12
$3.65
-68%
Current Price
2026-10-02
$4.32
-61%
SPAC Team
Underwriters
Extended Team Information
The team includes healthcare executives and medical-technology entrepreneurs, operators and investors, with prior experience in healthcare companies, medical devices, public-company boards, private equity and investment management.